|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Magnesium sulfate#Adult Indications and Dosage]] |
| {{Magnesium sulfate}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Indications and Usage==
| |
| | |
| Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute [[hypomagnesemia]] accompanied by signs of tetany similar to those observed in [[hypocalcemia]]. In such cases, the serum magnesium (Mg++) level is usually below the lower limit of normal (1.5 to 2.5 mEq/liter) and the serum calcium (Ca++) level is normal (4.3 to 5.3 mEq/liter) or elevated.
| |
| | |
| In total parenteral nutrition (TPN), magnesium sulfate may be added to the nutrient admixture to correct or prevent [[hypomagnesemia]] which can arise during the course of therapy.
| |
| | |
| Magnesium Sulfate Injection, USP is also indicated as a parenteral anticonvulsant for the prevention and control of seizures (convulsions) in severe toxemia of pregnancy. It effectively prevents and controls the convulsions of [[eclampsia]] without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MAGNESIUM SULFATE (MAGNESIUM SULFATE HEPTAHYDRATE) INJECTION, SOLUTION [PHYSICIANS TOTAL CARE, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70f46528-7a1c-48e7-9f0f-7e920e708d63 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]]
| |